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Abstract: In the present work, four green processes have been compared to evaluate their potential
to obtain rosemary extracts with in vitro anti-proliferative activity against two colon cancer cell lines
(HT-29 and HCT116). The processes, carried out under optimal conditions, were: (1) pressurized
liquid extraction (PLE, using an hydroalcoholic mixture as solvent) at lab-scale; (2) Single-step
supercritical fluid extraction (SFE) at pilot scale; (3) Intensified two-step sequential SFE at pilot scale;
(4) Integrated PLE plus supercritical antisolvent fractionation (SAF) at pilot scale. Although higher
extraction yields were achieved by using PLE (38.46% dry weight), this extract provided the lowest
anti-proliferative activity with no observed cytotoxic effects at the assayed concentrations. On the
other hand, extracts obtained using the PLE + SAF process provided the most active rosemary
extracts against both colon cancer cell lines, with LC50 ranging from 11.2 to 12.4 µg/mL and from
21.8 to 31.9 µg/mL for HCT116 and HT-29, respectively. In general, active rosemary extracts were
characterized by containing carnosic acid (CA) and carnosol (CS) at concentrations above 263.7 and
33.9 mg/g extract, respectively. Some distinct compounds have been identified in the SAF extracts
(rosmaridiphenol and safficinolide), suggesting their possible role as additional contributors to the
observed strong anti-proliferative activity of CA and CS in SAF extracts.
Keywords: rosemary; supercritical fluid extraction (SFE); process intensification; subcritical fluids;
supercritical fluids; anti-proliferative; colon cancer cell; HT-29; HCT116
1. Introduction
Nowadays, supercritical fluid extraction (SFE) employing CO2 is an established industrial
process for the production of high added-value products. By 2014, there were more than 150 SFE
industrial plants with a total extraction volume of more than 500 L around the world. Many of these
production plants are generally devoted to the SFE of natural products, leading to the recovery of
high-value products which provide interesting options for their use in the nutraceutical and functional
food industry [1]. In this sense, the search for bioactive compounds or “target molecules” from
natural sources (marine-derived and agro-industrial products or their by-products) has become the
most important application of the scientific research of SFE [2–8]. According to the review work
recently published by Da Silva et al. (2016), the bioactivities from natural compounds obtained
by SFE from 2010 to 2015 were mainly antioxidant (41%), antitumor (18%) and antibacterial (10%),
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followed by antiviral, antimicrobial, anti-inflammatory and anticholinesterase activity (in a total of
5%) [2]. In this regard, the recovery of bioactive compounds from herbs and spices (especially those
belonging to the Lamiaceae family) employing supercritical and subcritical fluids has been intensified
in the last 10 years [5,9,10], mainly due to several biological properties such as: antioxidant [11–13],
antimicrobial [14–17], anti-proliferative [18,19], antitumor [20,21], anti-inflammatory [22–24] and
anti-obesity [25,26], among others. Rosemary-leaf extracts (Rosmarinus officinalis L.) have received
special attention since European Food Safety Authority and U.S. Food and Drug Administration
approved their use as food additive, demonstrating to be safe for human health at specific
compositions [27,28]. Several rosemary compounds, principally carnosol (CS) [29–32], carnosic acid
(CA) [33–35], and ursolic acid [36–38], have demonstrated different anticancer activities, such as
anti-proliferative, antiinvasive, and antitumorigenic effects, in a dose-dependent manner. Interestingly,
although several of the observed anti-proliferative effects of rosemary extracts have been commonly
attributed to some of these components, in many cases the effect of the complete extract is higher than
that exerted by the individual compounds [20,21,30,33,39,40]. In some cases, this general observation
has been attributed to the synergistic effect of the combination of the main bioactive compounds
with other unknown and minor compounds present in the extract [20,21]. These functional aspects of
rosemary extracts make necessary to standardize the extraction methodology to achieve an extract
composition that exhibits the pursued anti-proliferative activity. Some authors have demonstrated the
superior anti-proliferative activity of the SFE rosemary extracts compared to aqueous and methanolic
extracts in leukemia, lung, liver, prostate, breast and colon cancer cells [18,33]. In our laboratory,
the investigation of green processes extraction methodologies has mainly been focused on the
concentration enhancement of bioactive compounds in rosemary extracts by means of multistage
fractionation or combination of sub- and supercritical fluid methodologies with upstream process
optimization [41–43]. These strategies are in good agreement with the recent trends directed to the
development of new intensified and integrated processes, which seems to be more suitable for complex
vegetable matrixes such as rosemary [1,42,44,45]. In process intensification, the same multipurpose
equipment is used for different unit operations, while in the integrated process, the best process for
obtaining each product is sought, where different equipment is commonly employed [44]. The process
intensification concept using supercritical fluids has been recently applied in several areas as an option
for the future production of substitutes for petrochemical derivatives from biomass, mainly as source
of energy and biofuels [46,47]. We recently reported the use of a pilot scale SFE equipment to study a
two-sequential step SFE as intensification process. Following this strategy, it was possible to obtain
two fractions, one rich in volatile oil (containing 1,8-cineole and camphor) and the other rich in CA and
CS, being this latter fraction tested for its inhibitory activity against colon cancer cell proliferation [42].
On the other hand, process integration includes prior unit operation (fermentation, extraction, enzyme
pre-treatment, physical fractionation or size reduction) followed by sub-or supercritical extraction
or fractionation processes (supercritical chromatography, enzymatic conversion, precipitation and
coating of solutes, among others) [45]. Regarding this approach, recent reports suggest the combined
use of extraction processes, such as supercritical CO2 followed by pressurized liquid extraction (PLE,
employing ethanol and water) for improving the recovery of compounds with different polarities
and bio-functionalities [44,48–50]. Another exceptionally versatile process that has been used in the
integrated SF-processes is the Supercritical Antisolvent Fractionation (SAF), which benefits from
the antisolvent properties of supercritical carbon dioxide (SC-CO2) and allows for the precipitation
of insoluble compounds in the SC-CO2 organic solution mixture [45,51]. Following these ideas,
an integration of two lab-scale processes, PLE and SAF was carried out to obtain two fractions enriched
in different families of compounds: a raffinate fraction (enriched in phenolic acids, mainly rosmarinic
acid) and an extract fraction (enriched in phenolic diterpenes, mainly CA and CS) [41]. The integrated
process was optimized and the extract fraction showed improved in vitro anti-proliferative activity
against human colon adenocarcinoma cells. Once the processes have been optimized at lab-scale, it is
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mandatory to test their efficacy at large scale; this step is crucial for the future implementation of
standardized processes leading to a product with well-known composition and bioactivity.
Therefore, in the present work, a comparative study of the four types of green processes
previously developed at lab-scale was carried out to evaluate their potential to obtain rosemary
extracts with in vitro anti-proliferative activity against two colon cancer cell lines (HT-29 and HCT116).
The comparison was performed on several rosemary extracts obtained by PLE using an hydroalcoholic
mixture as solvent with standard lab-scale equipment (a); and three different processes at pilot scale,
namely, single-step SFE (b), two-step sequential SFE (process intensification, c), and PLE + SAF
(process integration, d). To achieve that, PLE + SAF process (d) was assessed at higher scale in the
present study, and the resulting extracts were compared in terms of yield, chemical composition,
and antioxidant and anti-proliferative activities to the extracts obtained by the other three previously
optimized processes (a–c). All the rosemary extracts were chemically characterized using different
MS-based analytical techniques in an attempt to correlate the presence of specific rosemary constituents
with the observed bioactivities.
2. Results and Discussion
2.1. Yield of Phenolic Compounds and Antioxidant Properties of the Extracts
In the present study, four green processes were selected based on previous works focused on the
enrichment of rosemary extracts on CA and CS [41,42], to investigate their potential for the production
of rosemary leaves’ extracts and fractions with potent in vitro anti-proliferative activity against colon
cancer cells. Thus, PLE process was chosen since it is suitable for providing a rosemary extract at lab
scale that can be also used to obtain the starting material required for other processes (see below).
In addition to this, we selected three different processes performed at pilot scale. Namely, a single-step
SFE process using ethanol as co-solvent (7%, w/w) [41], a two-step SFE process for further CA
enrichment of the extract [41] and an integrated process that involves PLE and supercritical antisolvent
fractionation [41]. A total of six rosemary extracts were obtained in duplicate using the conditions
summarized in Table 1. As mentioned, the SAF process, previously optimized at lab scale to obtain
extracts fractions enriched in the phenolic diterpenes [41], was performed at pilot scale in the present
work to obtain three different extracts (SAF1-3) to make them comparable with the other extracts
obtained at pilot scale. As can be observed in Table 2, PLE process provided the highest extraction
yield (38.46 g/100 g rosemary-leaf dry) due mainly to the polarity solvent and the lower selectivity of
this procedure. On the other hand, despite the co-solvent and other distinct SFE extraction conditions,
the low extraction yields of SFE1 and SFE2 processes were not significantly different. The extraction
yields (or recoveries, in this case) of the SAF processes were higher when the feed to SC-CO2 mass
flow ratio was the lowest. Thus, around 21% (w/w) of dry PLE extract was recovered employing
SAF1 conditions, in accordance with the values obtained at lab-scale [41]. Total phenol values were
statistically different among processes studied and did not correlate linearly (at confidence level of
95%) with the antioxidant activity, expressed as Trolox equivalent antioxidant capacity (TEAC) assay
(r = 0.64) and EC50 (half maximal effective concentration) (r = −0.23). The highest phenol amount
was achieved in PLE sample (233.9 mg Galic acid equivalent (GAE)/g extract), which is in agreement
with the nature of the solvent (ethanol/water mixture) employed to extract this kind of compounds.
However, this high total phenolic content (TPC) value for PLE extract does not correspond with the
highest TEAC and lowest EC50 values among the extracts obtained. For instance, SAF1 exhibited a
lower TPC value than PLE sample; however, their TEAC and EC50 values were 49% higher and 56%
lower, respectively. This evidence could suggest that other types of compounds present in this extract
had a positive influence on the antioxidant activity. A similar observation can be done for SFE2 and
SAF2 extracts. Interestingly, SAF2 and SAF3 showed very similar TEAC values but the concentrations
required to inhibit 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical by half were very different among
them. A similar discrepancy was observed in the analysis of SFE2 and PLE extracts. In support of
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these observations, Yesil-Celiktas et al. (2007) reported similar results, indicating that TEAC assay
did not show any correlation with phenol content (r = −0.17) and DPPH assay (r = 0.16), in rosemary
extracts obtained by SFE [52]. These phenomena could be explained by the mechanism employed
by 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radical which is not able to allow
for discrimination between the genuine antioxidant compounds and just expresses well by reducing
agents that react primarily by a single electron transfer mechanism [53]. Comparing the six extracts,
the conditions used to obtain SAF1 samples seemed to be the most adequate green alternative in order
to maximize total phenolic content and antioxidant activity. The potency of all the extracts to inhibit
colon cancer cell proliferation was next tested on HT-29 and HCT116 cell lines.














PLE PLE 100 150 - 24.0 76.0 ** 20
Single-step SFE SFE1 150 40 - - 7.0 * 300
Two-step SFE SFE2
300 40 - - 0 60
150 40 - - 7.0 * 120
SAF SAF1 100 40 0.025 55.8 44.2 ** 180
SAF SAF2 100 40 0.100 55.8 44.2 ** 60
SAF SAF3 100 40 0.025 24.0 76.0 ** 180
*: Ethanol as co-solvent; **: ethanol in the solvent mixture. SC-CO2: Supercritical carbon dioxide;
PLE: Pressurized liquid extraction; SAF: Supercritical antisolvent fractionation; SFE: Supercritical
fluid extraction.
Table 2. Extraction yield (% dry weight), total phenolic content (TPC) and antioxidant activity
(Trolox equivalent antioxidant capacity (TEAC) and 1,1-diphenyl-2-picrilhidrazyl (DPPH) assays)
obtained for the different extracts.
Sample Yield (g/100 g Sample) TPC 1 TEAC 2 EC50 3
PLE 38.46 d ± 1.99 233.88 f ± 4.43 2.75 b ± 0.04 7.70 d ± 0.33
SFE1 6.74 a ± 0.33 134.42 a ± 4.51 1.87 a ± 0.05 7.03 e ± 0.15
SFE2 4.68 a ± 0.01 169.01 b ± 8.61 2.64 b ± 0.03 5.61 c ± 0.11
SAF1 20.65 c ± 1.74 220.05 e ± 5.82 4.09 d ± 0.15 3.39 a ± 0.08
SAF2 5.74 a ± 0.45 203.04 d ± 7.81 3.67 c ± 0.09 4.12 b ± 0.12
SAF3 15.36 b ± 1.41 188.55 c ± 1.06 3.80 c ± 0.20 7.83 d ± 0.22
In each column, superscripts letters mean groups not statistically different (p > 0.05), as analyzed by one-way
ANOVA. 1 mg gallic acid equivalents (GAE) g−1 extract; 2 mmol trolox equivalents g−1 extract; 3 Efficient
concentrations, µg extract mL−1 obtained by DPPH assay.
2.2. Anti-Proliferative Activity of the Extracts
To determine the anti-proliferative effect of the polyphenol-enriched extracts, HT-29 and HCT116
cells were incubated with increasing concentrations of extracts (from 0 to 50 µg/ mL) for 24 and 72 h and
cell proliferation was analyzed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay. All the extracts exhibited a concentration-dependent anti-proliferative effect after both
exposure times (Figure S1, Supplementary Materials). In order to characterize the anti-proliferative
activity of these extracts in more detail and compare their potencies, the growth inhibition (GI50, as an
indicator for cytostaticity) and the lethal concentration (LC50, as an indicator for cytotoxicity), were
also determined in both cell lines in time course experiments at 24 and 72 h incubation times. As it is
shown in Figure 1, HT-29 and HCT116 cell lines showed different sensitivity to the extracts. Specifically,
HCT116 cells were less refractory to the inhibitory and cytotoxic effect of the three SAF extracts than
HT-29 cells. Thus, these particular extracts exhibited good cytostatic potential at concentrations below
10 µg/mL in HCT116 cells after 24 h-exposures, whereas GI50 values obtained in the assays with
HT-29 cells were above that concentration (Figure 1A). The superior potency of SAF extracts towards
HCT116 cells is also illustrated in Figure 1B, where it is shown that extract concentrations ranging
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from 11.2 to 12.4 µg/mL were sufficient to induce 50% HCT116 cell death (LC50), whereas higher
concentrations (from 21.8 to 31.9 µg/mL) were needed to exert a comparable cytotoxic effect in
the HT-29 cell line. To note, the activity of the three SAF extracts was statistically comparable in
HCT116 cells, whereas one of them, SAF3 extract, showed to be more effective than the other two
extracts against HT-29 cells. Regarding the latter cell line, it showed an extraordinary tolerance to
cytostatic concentrations of SFE1 extract after 72 h-exposure (Figure 1C). In general, the inhibitory
effects of the extracts did not significantly vary by the exposure time (Figure 1C,D). An exception to
this was observed with SFE1 extract whose effect was significantly stronger in HT-29 cells at 24 h
than at 72 h. These results suggest that both cytostatic and cytotoxic concentrations of SFE1 extract
allow prompt cell recovery with partial restoration of proliferation. On the other hand, PLE extract
exhibited the lowest anti-proliferative activity among the studied extracts, providing GI50 values
above 30 µg/mL for HCT116 cells whereas GI50 values for HT-29 cells were outside the testing range.
In addition, PLE extract did not exert cytotoxic effects at the assayed concentrations. In vitro studies
have often confirmed strong anti-proliferative effects to be associated with phenolic-rich rosemary
extracts [18,33,40,54–56]. Interestingly, in the present study, examination of the total phenolic content
of the six extracts (Table 2) indicated that there is a lack of positive correlation between the total
phenolics in the extracts and their anti-proliferative activity in both cell lines. This observation is
illustrated by PLE extract, which showed the highest phenolics content but exhibited the lowest
anti-proliferative activity in both cell lines. This lack of correlation suggests that the effect of the
extracts on cell proliferation and viability may be due to certain extract constituents. In this regard,
the anti-proliferative activity (and also the antioxidant activity) of rosemary extracts has frequently
been attributed to the presence of major diterpenes, CA and CS [19,57]. Nevertheless, individual
CA and CS in pure solutions or in binary mixtures at the same concentrations as those found in
rosemary extracts appear to exert lower inhibitory effects than the whole extracts [20,56]. In our
present study, to investigate the selectivity of each process for the extraction of specific bioactive
compounds (or groups of compounds) and their potential correlation with the anti-proliferative activity,
the chemical compositions of the extracts were assessed using different MS-based analytical techniques.
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Figure 1. Cytostatic (A,C) and cytotoxic (B,D) activities of the rosemary extract on HCT116 (white)
and HT-29 cells (grey) at different exposure times. Calculated GI50 values at 24 h (A) and 72 h (C);
calculated LC50 values at 24 h (B) and 72 h (D). Error bars represent standard error of the mean (SEM).
In each bar graph, mean values that do not share superscripts letters indicate that they differ by p < 0.05
as analyzed by one-way analysis of variance (ANOVA). Superscript letters (e–h) and (a–d) have been
used to indicate ANOVA results in HCT116 and HT-29 cell lines, respectively.
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2.3. Chemical Characterization of the Extracts by LC-DAD-MS, LC-Q/TOF-MS, and GC-MS
The quantification of main phenolic (CA and CS, carried out by liquid chromatography coupled to
Diode Array Detector and mass spectrometry (LC-DAD-MS)) and volatile compounds (1,8-cineole and
camphor, by gas chromatography coupled to mass spectrometry (GC-MS)) in the rosemary extracts
is presented in the Supplementary Materials (Table S1). Chromatographic data revealed that high
enrichment in CA and CS was achieved in all the extracts, ranging from 263.7 to 443.3 and from 33.9 to
88.9 mg/g extract, respectively (Figure 2A). An exception to this was PLE extract in which CA and CS
were only found at 105.0 and 10.7 mg/g extract, respectively. SFE2 extracts was the most enriched in
both diterpenes (443.3 and 88.9 mg/g extract, respectively), achieving an improved extract with more
than 50% (w/w) of these phenolic diterpenes in their total composition. Also, similar to the lab scale
approach [42], the CA + CS concentration, TPC and antioxidant activity in the pilot SAF scale were
found to be in the following order: SAF1 > SAF2 > SAF3. However, in terms of recovery, the lab-scale
process showed lower values. On the other hand, a comparison among SAF and the other processes
indicated a new order for CA + CS enrichment in the extracts as follows: SFE2 > SAF1 > SAF2 ≥ SFE1
> SAF3 > PLE.
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ext, CA and CS concentrations, as well as the sum of both concentrations in the extracts,
were compared to their anti-proliferative activity. As expected, the less active extract (PLE) was the
one containing the lowest CA and CS concentration. However, excluding the observation for PLE
extract, a lack of positive correlation bet een the extract potency and the CA and CS concentrations
as observed in the rest of the rosemary extracts. Interestingly, SAF3 extract was less enriched
in CA and CS than those obtained using antisolvent fractionation technology, but was the most
active (among SAF extracts) inhibiting cell proliferation and inducing cytotoxic effects in HT-29 cells.
Further ore, SFE1 and SAF2 extracts showed co parable CA and CS concentrations (p-value > 0.05;
Supplementary Materials, Table S1); however, their activities were strikingly different in both cell lines.
These results suggest the potential presence of other unidentified rosemary constituents that may
also contribute to the observed anti-proliferative effect of the extracts (especially in SAF3). This lack
of positive correlation between the concentration of the two major diterpenes in the extracts and
the level of inhibition of cell proliferation prompted us to examine other chemical constituents in
the extracts. Thus, UHPLC-qTOF-MS analysis of the extracts was performed to identify potential
active compounds present in the extracts. Although all extracts provided similar chromatographic
profiles (Supplementary Materials, Figure S2), interesting qualitative and quantitative differences
were observed among them. Table 3 summarizes the 29 resolved peaks and 17 compounds that have
been tentatively identified. The identified compounds could be classified according to their nature
as follows: phenolic acids (syringic acid, rosmarinic acid and tryhydroxycinnamic acid derivate),
flavonoids (gallocathechin and genkwanin), phenolic terpenes (rosmanol, epirosmanol/isorosmanol,
rosmadial, carnosol, carnosic acid, rosmaridiphenol, methyl carnosate/12-methoxycarnosic acid,
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betulinic acid, oleanolic acid and ursolic acid), dihydrocoumarins (safficinolide) and diterpene lactones
(11,12-dimethylrosmanol). Some works have previously described these families of compounds
typically found in rosemary extracts [10,27,43,58,59]. In order to detect if there exists a similarity among
extracts with potent anti-proliferative activity, results were examined to identify the compounds that
were exclusively present in the most potent extracts compared to those extracts with lower activities.
Interestingly, three signals with masses 207.064 (tryhydroxycinnamic acid derivate), 331.156 (NI3) and
315.197 (rosmaridiphenol) Da were only found in the three most potent extracts (SAF1-3), showing
maximum peak area values in the chromatographic analysis of SAF1 extract. With regard to the analysis
of this extract, it revealed a signal with mass 343.156 Da (safficinolide) that was not detected in any other
extract. Other common features observed in the three supercritical antisolvent fractionation extracts
were the higher enrichment in 11,12-dimethylrosmanol and the lower rosmanol peak area compared to
SFE1 and SFE2, suggesting that this latter diterpene is better extracted using SC-CO2 and SC-CO2 with
ethanol as solvents. To note, betulinic, oleanolic and ursolic acids show identical molecular formula,
and thus, the same m/z; however, they were tentatively identified by their retention times according
to a similar separation carried out by Kontogianni et al. (2013) [19]. The chromatographic profile of
SAF3 extract analysis showed maximum peak areas for signals at m/z 455.352 that may correspond
to ursolic acid (455.352 Da), a compound with demonstrated cytotoxic activity [19], and four other
masses that correspond to less polar compounds (467.317, 467.318, 615.406, and 551.374 Da).
Besides the low CA and CS content in PLE sample, this extract showed a distinctive
chromatographic profile compared to the rest of the extracts. For instance, peak signals with
masses corresponding to syringic acid, gallocathechin, rosmarinic acid and other two non-identified
compounds (NI1 and NI2) were exclusively detected in the analysis of PLE extract. The distinctive
presence of these phenolic acids and flavonoid evidences a higher selectivity for polar compounds of
the PLE process compared to the other extraction procedures. Furthermore, the analysis of PLE extract
also revealed that betulinic acid was only detected in this extract. Interestingly, Kontogianni et al.
(2013) attributed part of the cytotoxic activity observed in a CA-enriched rosemary extract obtained
using solid-liquid extraction to the presence of the triterpenoids betulinic and ursolic acids in addition
to CA [19]. More recently, in a study based on the fractionation of a rosemary extract obtained by
SFE, CA was the major contributor to the anti-proliferative activity, followed by CS and also betulinic
acid [58]. In that case, betulinic acid concentration in the extract was 2.1 µM, and the incubation of
HT-29 cells with a purified fraction from the same extract containing 81% betulinic acid and 19%
hinokione showed the same cytotoxicity as the whole extract. In another published work, Rzeski et al.
(2006) demonstrated that betulinic acid acts as an effective anticancer agent by inducing growth arrest
and apoptosis in concentration-dependent manner, with HT-29 cells being particularly sensitive to this
pentacyclic triterpenoid [60]. However, reported IC50 values for betulinic acid by different research
groups for the same cell model (HT-29) are discordant (2.7 µM, [60]; 13.9 µM, [61]; and 32.7 µM, [62]).
The extremely low aqueous solubility (<1 µM), high protein binding (>99%) and poor membrane
permeability of this compound [63,64] could explain the lack of robustness in data obtained under
slightly different culturing conditions. Interestingly, our findings indicate that betulinic acid was only
present in the less active extract, suggesting that this compound is not among the most relevant active
constituents in the rosemary extracts obtained in the present study. To gain further insight into the
chemical differences among the extracts, the main volatile compounds were identified and quantified
by GC-MS analysis.
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Table 3. Tentatively identification by Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry (LC-Q/TOF-MS) of compounds present in rosemary
leaf extracts.
Peak Rt (min) [H-M]− MolecularFormula Identification
Peak Area (Mean± SD) (× 106)
PLE SFE1 SFE2 SAF1 SAF2 SAF3
1 0.479 387.1171 C13 H24 O13 NI1 3.91 ± 0.24 - - - - -
2 0.994 198.0528 C9 H10 O5 Siringic acid 0.36 ± 0.02 - - - - -
3 1.737 306.0798 C15 H14 O7 Gallocathechin 0.67 ± 0.04 - - - - -
4 1.797 387.1678 C18 H28 O9 NI2 0.99 ± 0.03 - - - - -
5 2.274 360.0845 C18 H16 O8 Rosmarinic acid 4.10 ± 0.12 - - - - -
6 2.730 207.0636 C11 H12 O4 Tryhydroxycinnamic acid derivate - - - 1.024 c ± 0.006 0.71 b ± 0.01 0.61 a ± 0.05
7 3.178 345.1737 C20 H26 O5 Rosmanol 0.930 a ± 0.009 6.16 f ± 0.42 4.80 e ± 0.15 3.90 d ± 0.02 2.37 b ± 0.01 2.87 c ± 0.11
8 3.275 345.1706 C20 H26 O5 Epirosmanol/Isorosmanol - 1.72 b ± 0.06 1.53 a ± 0.01 2.68 c ± 0.15 1.80 b ± 0.007 1.69 a,b ± 0.07
9 3.392 283.0617 C16 H12 O5 Genkwanin 0.78 a ± 0.05 2.29 d ± 0.02 1.79 b ± 0.01 2.02 c ± 0.01 1.88 b ± 0.02 1.90 b,c ± 0.06
10 3.843 343.1563 C20 H24 O5 Safficinolide - - - 0.57 ± 0.01 - -
11 3.883 331.1562 C19 H24 O5 NI3 - - - 2.06 c ± 0.09 1.26 b ± 0.02 0.99 a ± 0.05
12 3.960 329.1754 C20 H26 O4 Carnosol 3.76 a ± 0.12 15.49 b ± 0.17 30.90 e ± 0.90 29.76 e ± 0.88 22.63 d ± 0.07 18.84 c ± 0.16
13 4.111 343.1630 C20 H24 O5 Rosmadial - 0.92 b ± 0.06 - 0.99 c ± 0.01 0.91 b ± 0.01 0.708 a ± 0.002
14 4.158 373.2037 C22 H30 O5 11,12-Dimethylrosmanol - - 2.17 a ± 0.14 4.53 c ± 0.23 3.22 b ± 0.03 3.26 b ± 0.02
15 4.258 325.1865 C21 H26 O3 NI4 1.39 a ± 0.06 2.29 c,d ± 0.25 1.86 b ± 0.14 1.96 b,c ± 0.24 2.51 d ± 0.03 1.37 c ± 0.08
16 4.338 331.1952 C20 H28 O4 Carnosic Acid 21.80 a ± 1.04 42.86 b ± 0.36 50.78 d ± 2.44 49.28 d ± 1.09 50.01 d ± 0.25 45.95 c ± 0.53
17 4.575 345.2133 C21 H30 O4 Methyl carnosate/12-methoxy-carnosic acid 1.50 a ± 0.04 8.04 b ± 0.25 12.63 d ± 0.65 12.42 d ± 0.89 12.33 d ± 0.14 9.95 c ± 0.43
18 4.753 315.1965 C20 H28 O3 Rosmaridiphenol - - - 0.50 b ± 0.02 0.509 b ± 0.008 0.21 a ±0.02
19 4.799 317.2107 C20 H30 O3 NI5 - 2.27 a,b ± 0.07 2.47 b ± 0.14 2.15 a ± 0.08 2.138 a ± 0.006 2.40 b ± 0.11
20 4.818 455.3422 C26 H48 O6 Betulinic Acid * 2.304 ± 0.003 - - - - -
21 4.976 455.3650 C30 H48 O3 Oleanolic acid * 7.99 c ± 0.52 5.56 b ± 0.22 5.15 b ± 0.08 4.08 a ± 0.14 5.25 b ± 0.03 5.14 b ± 0.32
22 5.110 455.3515 C30 H48 O3 Ursolic acid * - 1.84 c ± 0.19 1.51 b ± 0.05 1.368 a ± 0.009 1.542 b ± 0.007 2.24 d ± 0.02
23 5.441 479.2785 C30 H40 O5 NI6 - 1.07 d ± 0.02 0.60 a ± 0.04 0.94 c ± 0.07 0.759 b ± 0.007 1.15 d ± 0.08
24 5.621 331.1921 C20 H28 O4 NI7 - 0.12 a ± 0.02 1.61 d ± 0.10 1.89 e ± 0.01 0.521 c ± 0.004 0.33 b ± 0.03
25 6.414 467.3168 C30 H44 O4 NI8 1.23 a ± 0.01 4.42 d ± 0.16 4.99 e ± 0.31 1.63 b,c ± 0.04 1.79 c ± 0.03 5.48 f ± 0.02
26 6.658 467.3184 C30 H44 O4 NI9 0.83 a ± 0.06 3.32 c ± 0.11 2.38 b ± 0.08 1.06 d ± 0.03 1.03 a ± 0.02 4.48 d ± 0.17
27 6.840 615.4061 C33 H60 O10 NI10 0.075 a ± 0.018 0.50 c ± 0.04 0.33 b ± 0.02 - - 0.57 d ± 0.03
28 6.997 551.3749 C35 H52 O5 NI11 - 0.305 b ± 0.005 0.20 a ± 0.02 - - 0.46 c ± 0.03
29 7.290 535.3794 C35 H52 O4 NI12 - - 0.34 ± 0.02 - - -
a–f, for each peak (row), peak area mean values that do not share subscripts differ by p < 0.05 as analyzed by one-way ANOVA; * The order of these compounds is suggested according
to the identification performed by Kontogianni et al., 2013 [19].
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In all cases, 1,8-cineole and camphor were the two more abundant volatile compounds found
in the GC chromatograms profiles. These results are in good agreement with others reported in the
literature for supercritical fluids and hydrodistillated rosemary extracts [14,44,65]. As it is shown in
Figure 2B, quantitative data indicated that 1,8-cineole and camphor were present at levels ranging
from 6.8 to 46.4 and from 8.6 to 50.3 mg/g extract, respectively. As a general trend, both monoterpenes
were more abundant in the more active extracts. Single-step and two-step sequential extraction
procedures seemed to be more selective for 1,8-cineole than camphor; the concentration of both volatile
monoterpenoids was lower in SFE2 (approximately 25% and 37% lower). This can be explained by
the removal of most aromatic and highly volatile components (mono- and sesquiterpenes, and their
oxygenated derivates) in the two-step sequential SFE process, leading to a more volatile-free extract
(SFE2). The opposite behavior occurred with the antisolvent fractionation methodology (SAF) where
extracts showed higher camphor content, which is less volatile than 1,8-cineole.
The cytotoxic activity of this latter compound has been demonstrated to be within the low
millimolar range against human colorectal HCT116 cells [66], which is well above (e.g., in 30 µg
extract/mL, the concentration of 1,8-cineole ranged from 1.32 to 9.03 µM) its concentration in the
rosemary extracts of our present study. A similar potency has been recently reported for camphor
monoterpene, exerting a 50% reduction in viability at concentrations of 5.5 and 4.5 mM, respectively in
HT-29 and HCT116 cells [67]. These published data suggest that both monoterpenes, when individually
assayed, have only modest cytotoxic activity compared to other compounds in the rosemary extracts.
According to our quantitative data, their content in the extracts seems to be below their reported
inhibitory concentrations. In spite of that, camphor and 1,8 cineole were, with respect to PLE extract,
enriched more than three-fold in the rest of the extracts with a comparably good activity. This is in
accordance with findings by other groups [55], indicating that the contribution of volatile monoterpenes
to the anti-proliferative activity of the extracts, particularly those with high CA content, cannot be
totally dismissed.
3. Materials and Methods
3.1. Samples and Reagents
Raw material consisted of rosemary (Rosmarinus officinalis L.) dried leaves obtained from
Herboristeria Murciana (Murcia, Spain) that were ground at low temperature (by its mixing with
small rocks of dry ice) employing a knife mill (Grindomix GM200, Retsch GmbH, Haan, Germany).
Sample particle size was in the range of 500 and 900 µm. Next, grinded samples were vacuum
packed and stored at 4 ◦C until further use. Carbon dioxide (99% purity) purchased from Carburos
Metálicos (X50S, Barcelona, Spain) was employed for the anti-solvent fractionation and supercritical
fluids extractions. Ethanol (99.5%), provided by VWR Chemicals (Fontenay-sous-Bois, France),
and ultrapure water, obtained from a Millipore system (Billerica, MA, USA), were used for PLE. Phenols
standards such as rosmarinic acid (RA, ≥98%), CA (≥97%), CS (≥98%), gallic acid, as well as other
chemicals as 1,8-cineole (99%), camphor (95%), 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic
acid (Trolox, ≥97%), ABTS (≥99%), DPPH (99%) were purchased from Sigma-Aldrich (Madrid,
Spain). Folin-Ciocalteu phenol reagent (2N) was provided by Merck (Darmstadt, Germany). For the
UHPLC-qTOF-MS analyses, MS grade ACN and water from LabScan (Dublin, Ireland) were employed.
Dry extracts were dissolved in DMSO (Sigma-Aldrich) at the appropriate concentrations and stored as
aliquots at −80 ◦C until their use in cell proliferation inhibition assays.
3.2. Rosemary-Leaf Extraction Procedures
The extraction procedures used in the present work to obtain the different rosemary extracts are
described in this section (main extraction parameters are also summarized in Table 1).
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3.2.1. Pressurized Liquid Extraction (PLE)
Hydroalcoholic rosemary extracts were obtained using an accelerated solvent extractor (ASE 200,
Dionex, Sunnyvale, CA, USA), equipped with a solvent controller unit. The extraction protocol has
been described in depth previously [41]. Briefly, a mixture of ethanol + water (80:20, v/v or 76:24 w/w)
was employed as solvent at 100 bar and 150 ◦C for 20 min. Successive extractions were performed until
complete 1000 mL of total extract. An aliquot was submitted to rotary evaporation and freeze-drying
(Labconco Corporation, Kansas City, MO, USA) to eliminate the ethanol and water, respectively,
thus obtaining the dry extract. The remaining liquid extract was stored with N2 atmosphere in the
dark at −20 ◦C until their use for the antisolvent fractionation experiments.
3.2.2. Single-Step SFE Process
Single-step SFE process was performed as previously reported in detail by Herrero et al. 2010 [43].
Extraction was carried out in triplicate in a pilot scale supercritical fluid extractor (model SF2000,
Thar Technology, Pittsburgh, PA, USA) including a 2 L cylinder extraction cell and two different
separators with independent control of temperature and pressure. The extraction conditions employed
for the single-step SFE process were 150 bar, 40 ◦C for 300 min, as described in Table 1. CO2 flow rate
was set to 60 g·min−1 and 7% ethanol was employed as co-solvent. After the extractions, ethanol was
eliminated by rotary evaporation (R-210, Büchi Labortechnik AG, Flawil, Switzerland). The extracts
were stored with N2 atmosphere in the dark at −20 ◦C.
3.2.3. Two-Step Sequential SFE
The same equipment employed for the single-step SFE process was used for the two-sequential
SFE extraction as described by Sánchez-Camargo et al. (2014) [42]. The extraction protocol involved
two consecutive steps with the following conditions: (1) 300 bar for 60 min and (2) 150 bar, 7% ethanol
(w/w) for 120 min. Both stages were performed at 40 ◦C and using 60 g·min−1 of CO2 flow. Once the
extracts were obtained in triplicate, ethanol was also eliminated by rotary evaporation. Dried extracts
were kept at −20 ◦C, in the dark and in N2 storage atmosphere.
3.2.4. Supercritical Antisolvent Fractionation (SAF) at Pilot Scale
A semi-continuous SAF was carried out in a Spe-ed Helix™ supercritical fluid extractor from
Applied Separations (Allentown, PA, USA). Originally, this equipment was designed to carry out
SFE (with or without a co-solvent) and subcritical water extraction (SWE); in the present work,
some modifications were introduced in the system in order to use it as a SAF at pilot scale (Figure 1).
Owing to the unavailability of a pilot-scale PLE equipment and in order to obtain enough volume
of PLE extract to feed SAF processes, PLE extract was made of a pool of extracts obtained in various
independent extractions using lab-scale PLE equipment. Then, based on previous lab scale results [41]
three different extraction conditions (see Table 1) were selected to be compared, and a 60-fold scale up
from bench to pilot scale was achieved. After the PLE process, the resulting hydroalcoholic rosemary
extract was properly diluted to obtain the extracts with 44.2% and 76.0% (w/w) of ethanol (or 50% and
80% (v/v) ethanol, respectively), for SAF1-2 and SAF3, respectively and according to the previously
optimized conditions. Then, diluted extracts were filtered through Whatman cellulose filter paper
and 100 mL samples were employed for each fractionation, accomplished in triplicate. In the Figure 3
is showed an scheme of the SAF pilot scale equipment employed. Briefly, CO2 was provided from a
pressurized cylinder (1), subcooled in a chiller (2) and then conducted to a high pressure pump (3).
Immediately, the CO2 was compressed at 100 bar and continuously pumped at a flow of 10 L·min−1
adjusted by a heated micrometering valve (HMMV) (8) at the exit of the system through of CO2
mass flowmeter (10). At the same time, PLE extract (5) was fed through another high pressure pump
at suitable flow according to feed/SC-CO2 rate (6). In a T-tube device, the CO2 (4) and the feed
(rosemary extract) was mixed before reaching the raffinate chamber separation. A polypropylene
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vessel (250 mL) was placed inside the high-pressure stainless-steel extraction cell to act as precipitation
raffinate vessel (7). The temperature of the raffinate separation chamber was kept at 40 ◦C by a
heating jacket and measured by an internal thermocouple. Once the aqueous fraction was separated,
the fraction soluble in SC–CO2 + ethanol was precipitated in a glass bottle (9) acting as extract chamber
separation, which was kept at room temperature (25 ◦C). During the SAF time, a whole process
overview was carried out through to a software and screen coupled to the system. After obtaining
the extract fraction, the ethanol was removed by rotary evaporation and the water was eliminated
by freeze-drying (Labconco Corporation, Kansas City, MO, USA). Dried extracts were kept under
freezing at −20 ◦C N2 atmosphere until analysis. The extraction yield (or recovery) was determined
gravimetrically, as the ratio of the mass of dry extract recovered in the separators and the mass of dry
PLE extract fed, and expressed as a percentage.
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3.3. Chemical Characterization of Rosemary Extracts
3.3.1. Liquid Chromatography-Diode Array Detection-Mass Spectrometry
Major phenolic compounds typically present in rosemary extracts (CA and CS) were quantified
employing an ACCELA UHPLC system (Thermo Scientific™, San Jose, , USA) coupled to a TSQ
Quantum (Thermo Scientific™) triple quadrupole analyzer via an electrospray interface. Briefly,
the analytical conditions employed consisted on the use of a Hypersil Gold column (50 mm × 2.1 mm,
d.p. 1.9 µm) (Thermo Scientific™) using as mobile phases 0.1% formic acid in acetonitrile (A) and
0.1% formic acid in water (B) eluted according to the following gradient: 0 min, 95% B; 0.35 min,
95% B; 3.5 min, 40% B; 6.2 min, 5% B; 7 min, 95% B; 10 min, 95% B. The flow rate was 0.4 mL/min
and the injection volume was 5 µL. The diode array detector recorded the spectra from 200 to
450 nm. Calibration curves were constructed using external calibration method to quantify CA
and CS (0.0625–2.0 µg/mL and 0.313–5.0 µg/mL, respectively). The mass spectrometer was operated
in the negative electrospray ionization (ESI) mode using multiple reaction monitoring (MRM) with
a Q1 and Q3 resolution of 0.7 Da FWHM, scan width 0.010 Da and scan time of 0.10 s. The values
corresponding to the tube lens voltage and collision energy for each ion transition were optimized
for each quantified compound: carnosic acid m/z 331.14 ([ -H]−) and m/z 287.19 ([M-H]−, product
ion using 62 and 26 as tube lens value (TLV) and CE, respectively), and for carnosol /z 329.16
([M-H]−) and 285.1 m/z ([M-H]−, r t i sing 45 V and 20 V as TLV and CE, respectively).
3.3.2. Liquid Chromatography-Quadrupole Time-Of-Flight Mass Spectrometry (LC- /T F-MS)
To obtain a more complete ch mi al characteriz tion of the r semary extr cts, these were analyzed
by liquid chromatograp y coupled to a high-resolution mas spectro eter. It consis d of an ultrahigh
performance liquid chromatography (UHPLC) system 1290 from Agilent (Agilent Technologies,
Santa Clara, CA, U A) coupled to a quadrupole-time-of-flight mass spectr meter (Q/TOF MS) Agil nt
6540 that was equipped with n orthogonal ESI source (A ilent Jet Stream, AJS, Santa Clara, CA,
USA), and controlled by a PC running the Mass Hunter Workstation software 4.0 (MH) from Agilent.
The analyses were performed in negative ion mode. Chromatographic separation of the extracts was
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achieved using a Hypersil Gold column (50 mm × 2.1 mm, d.p. 1.9 µm) (Thermo Scientific™) with
a mobile phase composition of acetonitrile (+0.1% formic acid, A) and water (+0.1% formic acid, B).
The gradient program was as follows: 0 min, 95% B; 0.35 min, 95% B; 3.5 min, 30% B; 6.2 min, 5%
B; 9 min, 95% B. The flow rate was 0.4 mL/min with an injection volume of 2 µL. The diode array
detector recorded the spectra from 200 to 450 nm. The extracts were injected to a concentration of
50 µg/mL. MS parameters were the following: capillary voltage, 4000 V; nebulizer pressure, 30 psi;
drying gas flow rate, 10 L/min; gas temperature, 300 ◦C; skimmer voltage, 45 V; fragmentor voltage,
125 V. The QTOF-MS was set to acquire m/z ranging between 50 and 1100 amu at a scan rate of
5 spectra per s. External calibration of the TOF MS was carried out using a commercial mixture from
Agilent with the following m/z values: 301.9981, 601.9790, 1033.9881, 1333.9689, 1633.9498, 1933.9306,
2233.9115, 2533.8923 and 2833.8731. The identification of CA and CS was based on the standard
samples. The other compounds were tentatively identified in accordance with the molecular formula
and the exact mass of the compound.
3.3.3. Gas Chromatography-Mass Spectrometry (GC-MS)
The main volatile compounds (camphor and 1,8-cineole) in rosemary extracts were quantified
using the GC-MS method developed by Sánchez-Camargo et al. (2014) [42] with some modifications.
A GCMS-QP2010 plus system (Shimadzu, Kyoto, Japan) equipped with a DB-5ms column
(30 m × 0.25 mm I.D. × 0.25 µm df, Quadrex Corporation, Woodbridge, CT, USA) was used. The oven
temperature program for the separation was carried out as follow: 60 ◦C, held for 4 min, and then
raised to 100 ◦C at 3 ◦C/min followed by an increase to 110 ◦C at 1 ◦C/min, and then to 150 ◦C at
5 ◦C/min. Finally, the temperature was raised to 300 ◦C at 15 ◦C/min and this value was held for
25 min. Injection volume was 1.6 µL in split mode (split ratio 1:10) maintaining an injector temperature
of 250 ◦C. The carrier gas employed was He at 36.4 cm·s−1. MS detection parameters were: interface
and source temperatures were 280 ◦C and 230 ◦C, respectively; mass range, m/z 40–500; scan speed:
2500 amu/s; event time 0.20 s. Collection and handling of data was performed using the GCMS
solution (ver. 2.50 SU3, Shimadzu) software. A commercial mass spectral database (Wiley) and the
linear retention indices (LRI) of the resolved peaks were used to identify the different compounds.
For the determination of LRIs, a hydrocarbon mixture ranging from C8 to C30 (Hydrocarbons/C5–C30,
straight-chain alkanes, Sigma-Aldrich) was employed and analyzed under the same experimental
conditions as the sample. After identification, calibration curves of camphor and 1,8-cineole were
employed to quantify their content in the sample (2.5–25.0 µg/mL, for both compounds). GC-MS
analyses were carried out in triplicate.
3.4. Total Phenols Content (Folin-Ciocateu Method)
The quantification of total phenols content (TPC) in the rosemary extracts was carried out using
the Folin–Ciocalteu method with some modifications [68]. Briefly, 600 µL of water were mixed with
10 µL of each extracts (2.5–5 mg/mL of rosemary extract in ethanol or ethanol: water mixtures) to
which 50 µL of undiluted Folin–Ciocalteu reagent (2N) was subsequently added. After 1 min, 150 µL
of 20% (w/v) Na2CO3 were added and the volume was made up to 1.0 mL with water. After 2 h
of incubation at 25 ◦C, 300 µL of the mixture was transferred into a well of a 96-well microplate.
The absorbance was measured at 760 nm in a microplate spectrophotometer reader (Synergy HT,
Bio Tek Instruments, Winooski, VT, USA). A gallic acid calibration curve (0.032–2.00 mg/mL) was
elaborated in the same way and the TPC was expressed as mg of gallic acid (GAE) per g of extract.
All analyses were done in triplicate.
3.5. Antioxidant Activity In Vitro Assays
3.5.1. DPPH Radical Scavenging Assay
The antioxidant activity was determined following the adjusted procedure described by
Brand-Williams, Cuvelier and Berset (1995) [69] employing 1,1-diphenyl-2-picrilhidrazyl (DPPH)
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reagent. A stock solution was prepared dissolving 23.5 mg of DPPH in 100 mL of methanol which was
further diluted 1:10 with methanol to give the working solution. Both stock and working solutions
were stored at 4 ◦C until use. A volume of 975 µL of DPPH diluted solution was added to 25 µL of
each extract concentration solution and the reaction was kept at darkness for 4 h at room temperature.
Different concentrations (from 0.0625 to 0.5 mg/mL) of each extract were tested. Once the reaction was
finished, 300 µL of this mixture was transferred into a well of a microplate, and the absorbance was
measured at 516 nm in a microplate spectrophotometer reader (Synergy HT). DPPH–methanol solution
was used as a reference sample. The DPPH concentration remaining in the reaction medium was
calculated from a calibration curve. The extract concentration (expressed in µg/mL) responsible for a
50% decrease in the initial activity of the DPPH (EC50, µg/mL) was calculated by linear regression of
the percentage remaining DPPH curve obtained for all the extract concentrations. Therefore, the lower
the EC50 value, the higher the antioxidant capacity. Measurements were done in triplicate.
3.5.2. TEAC Assay
The antioxidant capacity of the different rosemary extracts was determined by TEAC assay
following the ABTS radical method based on the procedure described by Re et al. (1999) with some
modifications [70]. ABTS•+ radical was produced by reacting 7 mM ABTS and 2.45 mM potassium
persulfate in the dark at room temperature during 16 h before its use. The aqueous ABTS•+ solution
was diluted with 5 mM phosphate buffer (pH 7.4) until achieve an absorbance of 0.7 (±0.02) at 734 nm.
One mL of ABTS•+ solution was mixed with 10 microliters of sample (five different concentrations) in a
1.5-mL vial and 300 µL of the mixture were transferred into a 96-well microplate. The absorbance was
measured at 734 nm every 5 min during 45 min in a microplate spectrophotometer reader (Synergy HT).
Trolox was used as a reference standard and results were expressed as TEAC values (mmol of Trolox/g
extract). These values were obtained from five different concentrations of each extract tested (between
0.0625–1 mg/mL) in the assay giving a linear response between 20% and 80% blank absorbance.
All analyses were done in triplicate.
3.6. Cell Culture
Colon adenocarcinoma HT-29 and HCT116 cell lines were purchased from ATCC (American
Type Culture Collection, LGC Promochem, UK). Cells were cultured in McCoy’s 5A supplemented
with 10% (v/v) heat inactivated FBS (Fetal Bovine Serum), 50 U/mL streptomycin, and 50 U/mL
penicillin G, in humidified atmosphere and 5% CO2 at 37 ◦C. Cells were trypsinized when reached
~50% confluence, neutralized with culture medium, seeded at 5000 cells/well, and allowed to adhere
overnight at 37 ◦C. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay method
was used to assess the antiproliferative activity of the extracts. Briefly, cells were incubated with the
vehicle (0.2% (v/v) DMSO) regarded as untreated controls or with different extract concentrations and
incubated for different times (24 and 72 h). After incubations, cells were incubated with MTT solution
(0.5 mg/mL) at 37 ◦C for 3 h. Then, the medium was aspirated, and the purple formazan crystals were
dissolved in DMSO. The absorbance at 570 nm was measured in a microplate reader (Synergy HT).
Based on the NIH definitions [71], the percentage of growth (PG) was calculated with the formula
PG = 100 [(T − T0)/(C − T0)] when T ≥ T0, or PG = 100 [(T − T0)/C] when T < T0, T being the optical
density of treated cells, C the optical density of control cells, and T0 the optical density at time zero.
Then, PG values were used to calculate the parameters related with cell proliferation after 24 h of
treatment (GI50, 50% growth inhibition; and LC50, 50% lethal concentration) using SigmaPlot v12.5
software (Systat Software Inc., Erkrath, Germany). The results are provided as the mean ± SEM of at
least three independent experiments, each performed in triplicate.
3.7. Statistical Analysis
Data analysis were carried out using the software Statgraphics Centurion XVI® (StatPoint
Technologies, Inc., Warrenton, VA, USA) using a level of significance set at 95%. One-way
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analysis of variance (ANOVA), together with F-test, was employed to group extracts, based on
statistically significant differences. Mean values were compared using Student-Newman-Keuls
multiple comparison procedure and differences were considered statistically significant if p < 0.05.
4. Conclusions
Taken together, our data highlight the good potential of novel green extraction strategies for
obtaining rosemary extracts with potent inhibitory activity of cancer cell proliferation. The most active
rosemary extracts were characterized by containing CA and CS at concentrations above 263.7 and
33.9 mg/g extract, respectively. However, above those concentrations, a lack of positive correlation
between the extract potency and the CA and CS content was observed, which suggest the potential
presence of other unidentified constituents that may also contribute to the observed anti-proliferative
effect of the rosemary extracts. The extracts obtained using an integrated process that involved PLE and
SAF provided the most active rosemary extracts against both colon cancer cell lines. The compounds
tentatively identified as rosmaridiphenol and safficinolide were exclusively identified in SAF1-3 and
SAF1 extracts, respectively, suggesting that they are possible additional contributors to the observed
strong anti-proliferative activity of CA and CS in SAF extracts. Contrasting with published data
that suggest betulinic acid as a relevant contributor to the anti-proliferative activity of rosemary
extracts, our data indicate this compound is not among the most active constituents in the rosemary
extracts obtained in the present work. In addition, although the concentrations of the two major
monoterpenes in the extracts are well below their reported active concentration in the same cell models,
their potential synergistic contributions to the anti-proliferative activity of the extracts should not
be dismissed. This study also illustrates the complexity of assigning the anti-proliferative activity
to individual or group of compounds in complex extracts when more than one compound is active.
This challenging task is crucial for the development of extraction processes that provide optimal
content of active compounds.
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